Teva Pharmaceutical Industries Ltd
TEVA30.330USD
+0.010+0.03%
收盤 12/19, 16:00（美東）報價延遲15分鐘
34.80B總市值
48.75本益比TTM
關於 Teva Pharmaceutical Industries Ltd 公司
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Teva Pharmaceutical Industries Ltd簡介
公司代碼TEVA
公司名稱Teva Pharmaceutical Industries Ltd
上市日期Feb 06, 2087
CEOFrancis (Richard D)
員工數量33892
證券類型Depository Receipt
年結日Feb 06
公司地址124 Dvora Hanevi'a St.
城市TEL AVIV-YAFO
上市交易所NASDAQ OMX NASDAQ Basic NYSE
國家Israel
郵編6944020
電話97239148213
網址https://www.tevapharm.com/
公司代碼TEVA
上市日期Feb 06, 2087
CEOFrancis (Richard D)
Teva Pharmaceutical Industries Ltd公司高管
名稱
名稱/職務
職務
持股
持股變動
Prof. Varda Shalev
Prof. Varda Shalev
Independent Director
Independent Director
22.50K
+74.83%
Ms. Christine (Chris) Fox
Ms. Christine (Chris) Fox
Executive Vice President - U.S. Commercial
Executive Vice President - U.S. Commercial
14.28K
--
Mr. David R. McAvoy
Mr. David R. McAvoy
Executive Vice President, Chief Legal Officer
Executive Vice President, Chief Legal Officer
13.03K
+9.34%
Mr. Evan Lippman
Mr. Evan Lippman
Executive Vice President - Business Development
Executive Vice President - Business Development
--
--
Mr. Placid Jover
Mr. Placid Jover
Executive Vice President, Chief Human Resources Officer
Executive Vice President, Chief Human Resources Officer
--
--
Mr. Richard Daniell
Mr. Richard Daniell
Executive Vice President - European Commercial
Executive Vice President - European Commercial
--
--
Mr. Eliyahu Sharon (Eli) Kalif
Mr. Eliyahu Sharon (Eli) Kalif
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Mr. Matthew Shields
Mr. Matthew Shields
Executive Vice President - Teva Global Operations
Executive Vice President - Teva Global Operations
--
--
Mr. Chen Lichtenstein
Mr. Chen Lichtenstein
Independent Director
Independent Director
--
--
Dr. Sol J. Barer, Ph.D.
Dr. Sol J. Barer, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Prof. Varda Shalev
Prof. Varda Shalev
Independent Director
Independent Director
22.50K
+74.83%
Ms. Christine (Chris) Fox
Ms. Christine (Chris) Fox
Executive Vice President - U.S. Commercial
Executive Vice President - U.S. Commercial
14.28K
--
Mr. David R. McAvoy
Mr. David R. McAvoy
Executive Vice President, Chief Legal Officer
Executive Vice President, Chief Legal Officer
13.03K
+9.34%
Mr. Evan Lippman
Mr. Evan Lippman
Executive Vice President - Business Development
Executive Vice President - Business Development
--
--
Mr. Placid Jover
Mr. Placid Jover
Executive Vice President, Chief Human Resources Officer
Executive Vice President, Chief Human Resources Officer
--
--
Mr. Richard Daniell
Mr. Richard Daniell
Executive Vice President - European Commercial
Executive Vice President - European Commercial
--
--
收入明細
單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
Generic products
2.41B
57.73%
AUSTEDO
498.00M
11.93%
Anda
365.00M
8.74%
Other
247.00M
5.91%
AJOVY
154.00M
3.69%
其他
501.00M
12.00%
地區USD
名稱
營收
佔比
United States
2.15B
51.51%
Europe
1.30B
31.06%
International Markets
495.00M
11.85%
Other
232.00M
5.56%
業務
地區
業務USD
名稱
營收
佔比
Generic products
2.41B
57.73%
AUSTEDO
498.00M
11.93%
Anda
365.00M
8.74%
Other
247.00M
5.91%
AJOVY
154.00M
3.69%
其他
501.00M
12.00%
股東統計
更新時間: 11月16日 週日
更新時間: 11月16日 週日
持股股東
股東類型
持股股東
持股股東
佔比
Phoenix Investment and Finances Ltd
3.60%
Menora Mivtachim Insurance Ltd.
3.39%
Harel Insurance Investments and Financial Services Ltd
3.29%
BlackRock Institutional Trust Company, N.A.
3.04%
Migdal Insurance and Financial Holdings Ltd
2.84%
其他
83.84%
持股股東
持股股東
佔比
Phoenix Investment and Finances Ltd
3.60%
Menora Mivtachim Insurance Ltd.
3.39%
Harel Insurance Investments and Financial Services Ltd
3.29%
BlackRock Institutional Trust Company, N.A.
3.04%
Migdal Insurance and Financial Holdings Ltd
2.84%
其他
83.84%
股東類型
持股股東
佔比
Investment Advisor
22.99%
Investment Advisor/Hedge Fund
12.47%
Hedge Fund
10.45%
Insurance Company
6.24%
Research Firm
2.35%
Pension Fund
1.69%
Family Office
1.47%
Bank and Trust
0.90%
Sovereign Wealth Fund
0.24%
其他
41.19%
機構持股
更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
1124
742.23M
64.70%
-84.92M
2025Q2
1100
749.18M
65.31%
-13.97M
2025Q1
1130
727.69M
63.46%
-282.41K
2024Q4
1087
683.52M
59.66%
-22.86M
2024Q3
1029
663.95M
58.60%
-6.13M
2024Q2
1002
631.05M
55.72%
-26.20M
2024Q1
950
595.83M
53.15%
-34.73M
2023Q4
932
601.27M
53.63%
+7.51M
2023Q3
929
573.53M
51.16%
-84.22M
2023Q2
921
512.98M
45.79%
-122.32M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Phoenix Investment and Finances Ltd
37.76M
3.29%
+10.30M
+37.49%
Jun 30, 2025
Menora Mivtachim Insurance Ltd.
57.40M
5%
+18.90M
+49.10%
Jul 16, 2025
Harel Insurance Investments and Financial Services Ltd
33.39M
2.91%
+11.33M
+51.39%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
33.89M
2.95%
+833.03K
+2.52%
Jun 30, 2025
Migdal Insurance and Financial Holdings Ltd
28.69M
2.5%
+2.35M
+8.92%
Jun 30, 2025
Clal Insurance Enterprises Holdings Ltd.
32.36M
2.82%
-5.43M
-14.37%
Jun 30, 2025
Lingotto Investment Management LLP
28.16M
2.45%
+302.98K
+1.09%
Jun 30, 2025
Rubric Capital Management LP
26.00M
2.27%
+450.00K
+1.76%
Jun 30, 2025
PointState Capital LP
20.71M
1.81%
+5.58M
+36.88%
Jun 30, 2025
Fidelity Management & Research Company LLC
50.63M
4.41%
-24.67M
-32.76%
Jun 30, 2025
查看更多
持股ETF
更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
iShares MSCI Israel ETF
7.76%
VanEck Israel ETF
7.5%
VanEck Pharmaceutical ETF
3.79%
First Trust WCM Developing World Equity ETF
3.16%
First Trust WCM International Equity ETF
2.64%
ARK Israel Innovative Technology ETF
1.81%
WealthTrust DBS Long Term Growth ETF
1.42%
WisdomTree International Multifactor Fund
0.77%
iShares Health Innovation Active ETF
0.69%
iShares MSCI Intl Value Factor ETF
0.46%
查看更多
iShares MSCI Israel ETF
佔比7.76%
VanEck Israel ETF
佔比7.5%
VanEck Pharmaceutical ETF
佔比3.79%
First Trust WCM Developing World Equity ETF
佔比3.16%
First Trust WCM International Equity ETF
佔比2.64%
ARK Israel Innovative Technology ETF
佔比1.81%
WealthTrust DBS Long Term Growth ETF
佔比1.42%
WisdomTree International Multifactor Fund
佔比0.77%
iShares Health Innovation Active ETF
佔比0.69%
iShares MSCI Intl Value Factor ETF
佔比0.46%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
常見問題
Teva Pharmaceutical Industries Ltd的前五大股東是誰？
Teva Pharmaceutical Industries Ltd的前五大股東如下：
Phoenix Investment and Finances Ltd持有股份：37.76M佔總股份比例：3.29%。
Menora Mivtachim Insurance Ltd.持有股份：57.40M佔總股份比例：5.00%。
Harel Insurance Investments and Financial Services Ltd持有股份：33.39M佔總股份比例：2.91%。
BlackRock Institutional Trust Company, N.A.持有股份：33.89M佔總股份比例：2.95%。
Migdal Insurance and Financial Holdings Ltd持有股份：28.69M佔總股份比例：2.50%。
Phoenix Investment and Finances Ltd持有股份：37.76M佔總股份比例：3.29%。
Menora Mivtachim Insurance Ltd.持有股份：57.40M佔總股份比例：5.00%。
Harel Insurance Investments and Financial Services Ltd持有股份：33.39M佔總股份比例：2.91%。
BlackRock Institutional Trust Company, N.A.持有股份：33.89M佔總股份比例：2.95%。
Migdal Insurance and Financial Holdings Ltd持有股份：28.69M佔總股份比例：2.50%。
Teva Pharmaceutical Industries Ltd的前三大股東類型是什麼？
Teva Pharmaceutical Industries Ltd 的前三大股東類型分別是：
Phoenix Investment and Finances Ltd
Menora Mivtachim Insurance Ltd.
Harel Insurance Investments and Financial Services Ltd
Phoenix Investment and Finances Ltd
Menora Mivtachim Insurance Ltd.
Harel Insurance Investments and Financial Services Ltd
有多少機構持有Teva Pharmaceutical Industries Ltd(TEVA)的股份？
截至2025Q3，共有1124家機構持有Teva Pharmaceutical Industries Ltd的股份，合計持有的股份價值約為742.23M，占公司總股份的64.70% 。與2025Q2相比，機構持股有所增加，增幅為-0.61%。
哪個業務部門對Teva Pharmaceutical Industries Ltd的收入貢獻最大？
在FY2025Q2，Generic products業務部門對Teva Pharmaceutical Industries Ltd的收入貢獻最大，創收2.41B，占總收入的57.73% 。
